Drugs / LUZ11
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02070432 | Feb 2014 → Jul 2016 | head and neck cancer | Luzitin SA | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LUZ11 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02070432 ↗ |
| Modality | Other / unclassified | “LUZ11 is a new photosensitizer for use in photodynamic therapy (PDT) of solid tumors” NCT02070432 ↗ |
| Route | Intravenous | “LUZ11 i.v. administration followed by laser light irradiation” NCT02070432 ↗ |